Last reviewed · How we verify
Stannous Fluoride Dentifrice — Competitive Intelligence Brief
marketed
Topical fluoride dentifrice
Tooth enamel (hydroxyapatite); bacterial cell membranes
Dental/Oral Health
Small molecule
Live · refreshed every 30 min
Target snapshot
Stannous Fluoride Dentifrice (Stannous Fluoride Dentifrice) — Procter and Gamble. Stannous fluoride strengthens tooth enamel and inhibits bacterial acid production to prevent dental caries and reduce plaque formation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Stannous Fluoride Dentifrice TARGET | Stannous Fluoride Dentifrice | Procter and Gamble | marketed | Topical fluoride dentifrice | Tooth enamel (hydroxyapatite); bacterial cell membranes |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Topical fluoride dentifrice class)
- Procter and Gamble · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Stannous Fluoride Dentifrice CI watch — RSS
- Stannous Fluoride Dentifrice CI watch — Atom
- Stannous Fluoride Dentifrice CI watch — JSON
- Stannous Fluoride Dentifrice alone — RSS
- Whole Topical fluoride dentifrice class — RSS
Cite this brief
Drug Landscape (2026). Stannous Fluoride Dentifrice — Competitive Intelligence Brief. https://druglandscape.com/ci/stannous-fluoride-dentifrice. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab